Retinopathy of prematurity training and education: A systematic review
- PMID: 40541843
- DOI: 10.1016/j.survophthal.2025.06.007
Retinopathy of prematurity training and education: A systematic review
Abstract
Globally, management of retinopathy of prematurity (ROP) is limited by a shortage of ophthalmologists who are adequately trained in identifying disease due to limited exposure in ophthalmology residencies and fellowships. We review the current state of ROP education and training and propose strategies to addressing the ROP workforce shortage. Adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic review was performed using PubMed, Embase, and SCOPUS. Terms that were used in the database searches include telemedicine, tele-education, tele-health, retinopathy of prematurity, artificial intelligence, medical education, training. Advancements in tele-education and artificial intelligence have paved the way for increased accessibility to ROP training, particularly in low- and middle-income countries; however, to ensure that these new modalities are effective in clinical practice and training, ophthalmology residency and fellowship programs must implement relevant education and training into their curricula.
Keywords: Medical education; Ophthalmology fellowship; Ophthalmology residency; Ophthalmology training; Retinopathy of prematurity; Tele-education.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: RVPC: Consultant for Alcon (Fort Worth, TX), AbbVie (North Chicago, IL), Genentech (San Francisco, CA), Adverum (Redwood City, CA), cofounder of Siloam Vision. JPC: Consultant for Genentech (San Francisco, CA), equity owner (Siloam Vision). KEJ: cofounder of Siloam Vision. ASC: consultant (Siloam Vision). RVPC: Unrestricted departmental funding from Research to Prevent Blindness, National Institute of Health (R01 HD107494, R01 EY019474, R01 EY036203, P30 EY010572). JPC: Research to Prevent Blindness (G), Malcolm Marquis Innovation Fund. KEJ: Chief Development Officer (Siloam Vision)
Publication types
LinkOut - more resources
Full Text Sources